ProCE Banner Activity

Managing ART Failure: Answering the Questions

Podcast Episodes

Hear from expert faculty as they discuss questions about managing ART failure including guideline definitions and recommendations, the likelihood of failure with resistance with first-line ART regimens, drug‒drug interaction considerations, and more.

Released: August 03, 2023

Share

Faculty

Daniel R. Kuritzkes

Daniel R. Kuritzkes, MD

Chief
Division of Infectious Diseases
Brigham and Women's Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Cristina Mussini

Cristina Mussini, MD

Head of Department of Infectious Diseases and Tropical Medicine
Full Professor of Infectious Diseases
Infectious Diseases Clinics, University Hospital
University of Modena and Reggio Emilia
Modena, Italy

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Daniel R. Kuritzkes, MD

Chief
Division of Infectious Diseases
Brigham and Women's Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Daniel R. Kuritzkes, MD: consultant/advisor/speaker: AbbVie, Gilead, GlaxoSmithKline, Immgenuity, Janssen, Merck, Roche, ViiV; researcher: Gilead, Merck, ViiV.

Cristina Mussini, MD

Head of Department of Infectious Diseases and Tropical Medicine
Full Professor of Infectious Diseases
Infectious Diseases Clinics, University Hospital
University of Modena and Reggio Emilia
Modena, Italy

Cristina Mussini, MD: consultant/advisor/speaker: Angelini, Janssen, MSD, Roche, ViiV; researcher: Gilead.